Back to 
Franklin Templeton Inc.
Franklin Templeton Inc.
STRO
Showing 3 of 18 quarters
Position history for Franklin Templeton Inc.'s holdings in Sutro Biopharma, Inc.
No. Franklin Templeton exited its STRO (Sutro Biopharma) position in Q1 2025. Its Q4 2024 13F listed 91,797 shares worth $168,907. Franklin Templeton first reported STRO in Q4 2020 and held it in 16 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$357,090
Total Shares Change
-93,235
Quarter-by-Quarter History
Other major holders of STRO: State Street Corp., RA Capital Management, L.P., Baillie Gifford & Co.